Director Wells David B exercised 28,638 shares at a strike of $58.28 and sold $2,287,603 worth of shares (28,638 units at $79.88) (SEC Form 4)
$TTD
Computer Software: Programming Data Processing
Technology
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Trade Desk, Inc. [ TTD ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 05/13/2025 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Class A Common Stock | 05/13/2025 | M | 6,990 | A | $58.458 | 73,975 | D | |||
| Class A Common Stock | 05/13/2025 | M | 1,390 | A | $58.458 | 75,365 | D | |||
| Class A Common Stock | 05/13/2025 | M | 670 | A | $58.458 | 76,035 | D | |||
| Class A Common Stock | 05/13/2025 | M | 220 | A | $58.458 | 76,255 | D | |||
| Class A Common Stock | 05/13/2025 | M | 6,826 | A | $49.03 | 83,081 | D | |||
| Class A Common Stock | 05/13/2025 | M | 1,365 | A | $49.03 | 84,446 | D | |||
| Class A Common Stock | 05/13/2025 | M | 655 | A | $49.03 | 85,101 | D | |||
| Class A Common Stock | 05/13/2025 | M | 218 | A | $49.03 | 85,319 | D | |||
| Class A Common Stock | 05/13/2025 | M | 7,282 | A | $66.26 | 92,601 | D | |||
| Class A Common Stock | 05/13/2025 | M | 1,374 | A | $66.26 | 93,975 | D | |||
| Class A Common Stock | 05/13/2025 | M | 1,374 | A | $66.26 | 95,349 | D | |||
| Class A Common Stock | 05/13/2025 | M | 274 | A | $66.26 | 95,623 | D | |||
| Class A Common Stock | 05/13/2025 | S | 28,638(1) | D | $79.88(2) | 66,985 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Stock Option (Right to Buy) | $58.458(3) | 05/13/2025 | M | 6,990 | (4) | 05/27/2031 | Class A Common Stock | 6,990 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $58.458(5) | 05/13/2025 | M | 1,390 | (4) | 05/27/2031 | Class A Common Stock | 1,390 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $58.458(6) | 05/13/2025 | M | 670 | (7) | 05/27/2031 | Class A Common Stock | 670 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $58.458(8) | 05/13/2025 | M | 220 | (9) | 05/27/2031 | Class A Common Stock | 220 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $49.03 | 05/13/2025 | M | 6,826 | (10) | 05/26/2032 | Class A Common Stock | 6,826 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $49.03 | 05/13/2025 | M | 1,365 | (10) | 05/26/2032 | Class A Common Stock | 1,365 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $49.03 | 05/13/2025 | M | 655 | (11) | 05/26/2032 | Class A Common Stock | 655 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $49.03 | 05/13/2025 | M | 218 | (12) | 05/26/2032 | Class A Common Stock | 218 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $66.26 | 05/13/2025 | M | 7,282 | (13) | 05/25/2033 | Class A Common Stock | 7,282 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $66.26 | 05/13/2025 | M | 1,374 | (13) | 05/25/2033 | Class A Common Stock | 1,374 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $66.26 | 05/13/2025 | M | 1,374 | (14) | 05/25/2033 | Class A Common Stock | 1,374 | $0 | 0 | D | ||||
| Stock Option (Right to Buy) | $66.26 | 05/13/2025 | M | 274 | (15) | 05/25/2033 | Class A Common Stock | 274 | $0 | 0 | D | ||||
| Explanation of Responses: |
| 1. These sales represent the aggregate shares from the twelve acquisitions reported above. |
| 2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3. This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. |
| 4. The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| 5. This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. |
| 6. This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. |
| 7. The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| 8. This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. |
| 9. The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| 10. The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| 11. The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| 12. The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| 13. The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| 14. The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| 15. The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| Remarks: |
| /s/ Kelli Faerber, Attorney-In-Fact for David B. Wells | 05/15/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||